Gender difference analysis of Xp11.2 translocation renal cell carcinomas’s attack rate: a meta-analysis and systematic review

[1]  B. Iványi,et al.  Clinicopathological Findings on 28 Cases with XP11.2 Renal Cell Carcinoma , 2020, Pathology & Oncology Research.

[2]  J. Hou,et al.  Magnetic resonance imaging findings of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in adults: a pilot study , 2018, Abdominal Radiology.

[3]  U. Capitanio,et al.  Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease , 2017, PloS one.

[4]  Dongmei Li,et al.  Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis , 2016, PloS one.

[5]  M. Gallucci,et al.  Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  C. Antonescu,et al.  TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers , 2016, The American journal of surgical pathology.

[7]  M. Sibony,et al.  Identification by FFPE RNA‐Seq of a new recurrent inversion leading to RBM10‐TFE3 fusion in renal cell carcinoma with subtle TFE3 break‐apart FISH pattern , 2016, Genes, chromosomes & cancer.

[8]  R. Mehra,et al.  MiT Family Translocation-Associated Renal Cell Carcinoma: A Contemporary Update With Emphasis on Morphologic, Immunophenotypic, and Molecular Mimics. , 2015, Archives of pathology & laboratory medicine.

[9]  Choung-Soo Kim,et al.  Clinicopathological features of Xp11.2 translocation renal cell carcinoma , 2015, Korean journal of urology.

[10]  Seok Ho Kang,et al.  Characteristics and prognostic value of papillary histologic subtype in nonmetastatic renal cell carcinoma in Korea: a multicenter study. , 2014, Urology journal.

[11]  E. Heard,et al.  X‐chromosome inactivation in development and cancer , 2014, FEBS letters.

[12]  Erika J. Thompson,et al.  Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes , 2014, Clinical Cancer Research.

[13]  M. Ladanyi,et al.  Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage , 2014, Modern Pathology.

[14]  Hong-cheng Song,et al.  Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions. , 2014, Journal of pediatric surgery.

[15]  W. Liang,et al.  Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study. , 2014, International journal of clinical and experimental pathology.

[16]  M. Rubin,et al.  Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing. , 2013, Neoplasia.

[17]  M. Ladanyi,et al.  Utilization of a TFE3 Break-apart FISH Assay in a Renal Tumor Consultation Service , 2013, The American journal of surgical pathology.

[18]  C. Pan,et al.  High chromosomal copy number alterations in Xp11 translocation renal cell carcinomas detected by array comparative genomic hybridization are associated with aggressive behavior. , 2013, The American journal of surgical pathology.

[19]  M. Stöckle,et al.  Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study. , 2012, European journal of cancer.

[20]  K. Chamie,et al.  Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. , 2012, The Journal of urology.

[21]  J. Cheville,et al.  TFE3 Rearrangements in Adult Renal Cell Carcinoma: Clinical and Pathologic Features With Outcome in a Large Series of Consecutively Treated Patients , 2012, The American journal of surgical pathology.

[22]  W. Linehan,et al.  Translocation Renal Cell Carcinomas in Adults: A Single-institution Experience , 2012, The American journal of surgical pathology.

[23]  Xiao-jun Zhou,et al.  Xp11.2 Translocation Renal Cell Carcinomas Have a Poorer Prognosis Than Non-Xp11.2 Translocation Carcinomas in Children and Young Adults: A Meta-analysis , 2010, International journal of surgical pathology.

[24]  M. Ladanyi,et al.  A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions , 2010, The American journal of surgical pathology.

[25]  Paul Russo,et al.  Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. , 2009, The Journal of urology.

[26]  Y. Ishikawa,et al.  Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry , 2009, Clinical Cancer Research.

[27]  L. Cheng,et al.  Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation‐associated and unusual clear cell subtypes , 2008, Histopathology.

[28]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.

[29]  M. Kattan,et al.  Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma , 2006, Annals of Surgical Oncology.

[30]  D. Coradini,et al.  Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. , 2005, Cancer research.

[31]  Jérôme Couturier,et al.  A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23) , 2003, Oncogene.

[32]  M. Ladanyi,et al.  Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay , 2003, The American journal of surgical pathology.

[33]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[34]  R. Jaenisch,et al.  DNA hypomethylation can activate Xist expression and silence X-linked genes. , 1996, Genes & development.

[35]  Carolyn J. Brown,et al.  A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome , 1991, Nature.

[36]  Lippincott Williams Wilkins,et al.  The American journal of surgical pathology , 1977 .